Content about treatment for obesity

June 27, 2012
FDA approves new obesity drug

The Food and Drug Administration has approved a new treatment for obesity in adults, the agency said Wednesday.

December 23, 2011
FDA panel to review Qnexa in February 2012

The Food and Drug Administration's Endocrinologic and Metabolic Drugs Advisory Committee is set to review an investigational treatment for obesity.

August 5, 2011
Amylin, Takeda discontinue development of obesity drug

Amylin Pharmaceuticals and Takeda Pharmaceutical have halted development of a treatment for obesity in mid-stage clinical trials, the two companies said.

August 1, 2011
Lannett receives FDA approval for generic Ionamin

The Food and Drug Administration has approved a generic version of a short-term adjunct treatment for obesity.

© 2013 Drug Store News. All Rights Reserved.